Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells

Oncology Reports

Volumn 20, Issue 4, 2008, Pages 785-792

  Kong, Eun Hee ^c   Kim, Yun Jin ^a   Kim, Young Jin ^a   Cho, Hyo Jin ^a   Yu, Sun Nyoung ^a   Kim, Kwang Youn ^a   Chang, Jeong Hyun ^d   Ahn, Soon Cheol ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University   (South Korea)

^c Kosin University   (South Korea)

^d Catholic University of Pusan   (South Korea)

Author keywords

Apoptosis; Caspase 3; Cell cycle; Piplartine; Prostate cancer cells

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANDROGEN; ANTINEOPLASTIC AGENT; CASPASE; CYCLIN DEPENDENT KINASE 1; DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PIPLARTINE; PROCASPASE 3; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL VACUOLE; CHROMATIN CONDENSATION; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG STRUCTURE; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; STRUCTURE ANALYSIS; UPREGULATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASE 3; CELL DIVISION; CELL LINE, TUMOR; CYCLIN B; DNA FRAGMENTATION; G2 PHASE; HUMANS; MALE; PIPERIDONES; POLY(ADP-RIBOSE) POLYMERASES; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 54949096135     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or_00000075     Document Type: Article

References (27)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ and Thun MJ: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005.
2. Swanson GP, Riggs M and Earle J: Failure after primary radiation or surgery for prostate cancer; differences in response to androgen ablation. J Urol 172: 525-528, 2004.
3. Swanson GP: Management of locally advanced prostate cancer: past, present, future. J Urol 176: S34-S41, 2006.
4. Rossi D and Gaidano G: Messengers of cell death: apoptotic signaling in health and disease. Haematologica 88: 212-218, 2003.
5. Gurumurthy S, Vasudevan KM and Rangnekar VM: Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev 20: 225-243, 2001.
6. Buttyan R, Shabsigh A, Perlman H and Colombel M: Regulation of apoptosis in the prostate gland by androgenic steroids. Trends Endocrinol Metab 10: 47-54, 1999.
7. Reddy L, Odhav Band Bhoola KD: Natural products for cancer prevention: a global perspective. Pharmacol Ther 99: 1-13, 2003.
8. Mann J: Natural products in cancer chemotherapy: past, present and future. Nat Rev Cancer 2: 143-148, 2002.
9. Lowe SW and Lin AW: Apoptosis in cancer. Carcinogenesis 21: 485-495, 2000.
10. Guseva NV, Taghiyev AF, Rokhlin OW and Cohen MB: Death receptor-induced cell death in prostate cancer. J Cell Biochem 91: 70-99, 2004.
11. Jiang C, Wang Z, Ganther H and Lu J: Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU145 prostate cancer cells. Cancer Res 61: 3062-3070, 2001.
12. Pilat MJ, Kamradt JM and Pienta KJ: Hormone resistance in prostate cancer. Cancer Metastasis Rev 17: 373-381, 1998-99,
13. Petrylak DP, Tangen CM, Hussain MH Jr, Lara PN, Jones JA, Taplin ME, Burch PA, Berry D, Moinpour C, Kohli M, Benson MC, Small EJ, Raghavan D and Crawford ED: Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med 351: 1513-1520, 2004.
14. Petrylak DP: The current role of chemotherapy in metastatic hormone-refractory prostate cancer. Urology 65: 3-7, 2005.
15. Kantoff PW: New agents in the therapy of hormonerefractory prostate cancer. Semin Oncol 22: 32-34, 1995.
16. Lampe JW: Spicing up a vegetarian diet: chemopreventive effects of phytochemicals. Am J Clin Nutr 78: S579-S583, 2003.
17. Parmar VS, Jain SC, Bisht KS, Jain R, Taneja P, Jha A, Tyagi OM, Prasad AK, Wengel J, Olsen CE and Boll PM: Phytochemistry of the genus Piper. Phytochemistry 46: 597-673, 1997.
18. Tsai IL, Lee FP, Wu CC, Duh CY, Ishikawa T, Chen JJ, Chen YC, Seki H and Chen IS: New cytotoxic cyclobutanoid amides, a new furanoid lignan and anti-platelet aggregation constituents from Piper arborescens. Planta Medica 71: 535-542, 2005.
19. Duh CY, Wu YC and Wang SK: Cytotoxic pyridone alkaloids from Piper aborescens. Phytochemistry 29: 2689-2691, 1990.
20. Silva RV, Navickiene HMD, Kato MJ, Bolzani VS, Méda CI, Young MCM and Furlan M: Antifungal amides from Piper arboreum and Piper tuberculatum. Phytochemistry 59: 521-527, 2002.
21. Wang G, Chen H, Huang M, Wang N, Zhang J, Zhang Y, Bai G, Fong WF, Yang M and Yao X: Methyl protodioscin induces G2/M cell cycle arrest and apoptosis in HepG2 liver cancer cells. Cancer Lett 241: 102-109, 2006.
22. Furre IE, Moller MT, Shahzidi S, Nesland JM and Peng Q: Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells. Apoptosis 11: 2031-2042, 2006.
23. Perez-Stable C: 2-Methoxyestradiol and paclitaxel have similar effects on the cell cycle and induction of apoptosis in prostate cancer cells. Cancer Lett 231: 49-64, 2006.
24. Huang EJ, Wu CC, Huang HP, Liu JY, Lin CS, Chang YZ, Lin JA, Lin JG, Chen LM, Lee SD, Kuo WW and Huang CY: Apoptotic and anti-proliferative effects of 17 beta-estradiol and 17 beta-estradiol-like compounds in the Hep3B cell line. Mol Cell Biochem 290: 1-7, 2006.
25. Huang YT, Pan SL, Guh JH, Chang YL, Lee FY, Kuo SC and Teng CM: YC-1 suppresses constitutive nuclear factor-kappa B activation and induces apoptosis in human prostate cancer cells. Mol Cancer Ther 4: 1628-1635, 2005.
26. Bezerra DP, Pessoa C, Moraes MO, Silveira ER, Lima MAS, Elmiro FJM and Costa-Lotufo LV: Antiproliferative effects of two amides, piperine and piplartine, from Piper species. Zeitschrift für Naturforschung 60: 539-543, 2005.
27. Masquelier M, Zhou QF, Gruber A and Vitols S: Relationship between daunorubicin concentration and apoptosis induction in leukemic cells. Biochem Pharmacol 67: 1047-1056, 2004.